<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200401046908N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-02</date_registration>
      <primary_sponsor>kharazmi University</primary_sponsor>
      <public_title>Comparison of gait retraining intervention along with feedback with  rehabilitation targeting exercises on biomechanics of patients with groin pain.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effect of gait retraining along with feedback with rehabilitation targeting exercises on trunk and lower extremity kinetic and kinematic of patients with groin pain.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>51</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46917</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: To randomize, the names of each subject are written on a ball after being selected and placed inside a bag, and a person is asked to take them out of the bag and randomly place 1: 1: 1 in one of three study groups, Blinding description: One researcher who is evaluating the outcome is kept blind. In this way, he does not know how the subjects are assigned to the groups and what treatment interventions each group of subjects receives. In this way, he does not make deliberate mistakes in his judgments and does not benefit from the new treatment intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Groin pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: This group will implement a targeted rehabilitation protocol that includes three levels; level 1 addressed intersegmental control and strength, level 2 involved linear running mechanics and increasing linear running load tolerance, and level 3 targeted multidirectional mechanics and the transition back to high intensity sprinting. Exercises are performed 3 days a week, one day in between, for 8 weeks. The rest time between each set is 30 seconds to 1 minute. Intervention 2: Intervention group 2: This group performs gait retraining along with visual and verbal feedback. Gait retraining is done on a treadmill. People run on the treadmill at a comfortable pace in all sessions. Visual feedback during running through a full-length mirror that is placed directly in front of the treadmill, and verbal feedback in the form of instructions such as "keeping the knees in line with the toes, reducing pelvic prolapse and maintaining pelvic symmetry, reducing vertical acceleration (by inducing a quiet and quiet walking style)" provided by the tester. In general, the training time starts from 15 minutes in the first session and is increased to 3 to 9 minutes per week. While feedback time is reduced from 100% in the first four weeks to 25% in the last few weeks and then removed. Exercises are followed 1 day a week for 8 weeks. Intervention 3: Control group: This group continues the specific routine exercises of their sport.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sarvenaz kazempour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Between the 8th and 10th Yadgar, 16 Metri Dovom street.</address>
        <city>Qaemshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4766657165</zip>
        <telephone>+98 11 4226 7159</telephone>
        <email>Kazempour.sarvenaz@yahoo.com</email>
        <affiliation>kharazmi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sarvenaz Kazempour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Between the 8th and 10th Yadgar, 16 Metri Dovom street.</address>
        <city>Qaemshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4766657165</zip>
        <telephone>+98 11 4226 7159</telephone>
        <email>Kazempour.sarvenaz@yahoo.com</email>
        <affiliation>kharazmi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men 18-35 years old have groin pain for at least 2 months
People who intend to return to the same level of preinjury participation in competitive multidirectional sports
Those who have a positive Squeeze test (at 45 degrees of hip flexion)
Those who have painful palpation in the tendon of the adductor or its connections to the pubic bone</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>People with hip joint osteoarthritis
Those with underlying medical conditions such as arthritis or infection
People who feel pain in the thoracolumbar area
Athletes who performed hip adductor strengthening exercises more than once a week for six months before the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: This group will implement a targeted rehabilitation protocol that includes three levels; level 1 addressed intersegmental control and strength, level 2 involved linear running mechanics and increasing linear running load tolerance, and level 3 targeted multidirectional mechanics and the transition back to high intensity sprinting. Exercises are performed 3 days a week, one day in between, for 8 weeks. The rest time between each set is 30 seconds to 1 minute.</i_keyword>
      <i_keyword>Intervention group 2: This group performs gait retraining along with visual and verbal feedback. Gait retraining is done on a treadmill. People run on the treadmill at a comfortable pace in all sessions. Visual feedback during running through a full-length mirror that is placed directly in front of the treadmill, and verbal feedback in the form of instructions such as "keeping the knees in line with the toes, reducing pelvic prolapse and maintaining pelvic symmetry, reducing vertical acceleration (by inducing a quiet and quiet walking style)" provided by the tester. In general, the training time starts from 15 minutes in the first session and is increased to 3 to 9 minutes per week. While feedback time is reduced from 100% in the first four weeks to 25% in the last few weeks and then removed. Exercises are followed 1 day a week for 8 weeks.</i_keyword>
      <i_keyword>Control group: This group continues the specific routine exercises of their sport.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Groin Pain. Timepoint: Pre and post test. Method of measurement: sphygmomanometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Kinetic: Ankle moment sagittal (plantar). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinetic: Ankle power sagittal (eccentric). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinetic: Ankle power sagittal (concentric). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinetic: Hip power sagittal (concentric). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinetic: Hip moment sagittal (extensor). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinetic: Knee power sagittal (concentric). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinetic: Hip moment frontal (adductor). Timepoint: Pre and post test. Method of measurement: Force plate.</sec_outcome>
      <sec_outcome>Kinematic: Thorax angles frontal (contralateral side flexion). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Pelvis angles transverse (contralateral rotation). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Pelvis angles frontal (contralateral side flexion). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Ankle angles sagittal (dorsiflexion). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Thorax angles transverse (ipsilateral rotation). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Hip angles sagittal (flexion). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Hip angles frontal (abduction). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Knee angles sagittal (flexion). Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
      <sec_outcome>Kinematic: Ground contact time. Timepoint: Pre and post test. Method of measurement: Three-dimensional motion analysis system.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>kharazmi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-12</approval_date>
        <contact_name>Ethics Committee in Kharazmi University Research</contact_name>
        <contact_address>Center for Human Movement Sciences Kharazmi University, End of Mirdamad, Sout Razan Street, Hesari Street, Keshvari Sport Complex. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
